Metric Finance
LearnFAQ
LearnFAQ

Learn / DLB

NYSE: DLB

Dolby Laboratories (DLB) stock, explained like you're 5

Dolby Laboratories trades on the New York Stock Exchange under the ticker DLB. It is a mid cap company in the multi sector companies industry, part of the sector, with a market value of about 5.5 billion dollars.

Ticker
DLB
Exchange
New York Stock Exchange
Industry
Multi Sector Companies
Size
Mid cap, about 5.5 billion dollars

Is Dolby Laboratories a small, medium or large cap company?

No. Dolby Laboratories is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Dolby Laboratories makes money

  • Selling products or services to its customers.
  • Growing sales while controlling costs.
  • Returning extra cash to shareholders in some cases.

What moves DLB stock

  • Quarterly results compared with what analysts expected.
  • News about its products, customers and competition.
  • Interest rates and the overall mood of the market.

In the news lately

  • Dolby Laboratories (NYSE:DLB) Stock Rating Cut to Strong Sell at Zacks Research (MarketBeat)
  • DLB Nov 2026 60.000 call (DLB261120C00060000) stock price, news, quote and history (Yahoo Finance UK)
  • What Dolby Labs Stock Means For Shareholders After Formula 1 Audio Deal (Simply Wall Street)
  • Q4 and full year results will be released after trading Nov. 17; Dolby's call starts at 2 p.m. PT. (Stock Titan)
  • Dolby Laboratories, Inc. Class A Actuals & Estimates (NYSE:DLB) (TradingView)

Follow DLB in your daily brief

Each trading day at 5 PM ET we post what happened to Dolby Laboratories and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow DLB

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Dolby Laboratories stock

What does Dolby Laboratories do?

Dolby Laboratories trades on the New York Stock Exchange under the ticker DLB. It is a mid cap company in the multi sector companies industry, part of the sector, with a market value of about 5.5 billion dollars.

What is the ticker symbol for Dolby Laboratories?

Dolby Laboratories trades under the ticker DLB on the New York Stock Exchange.

What is Dolby Laboratories's market cap?

Dolby Laboratories is a mid cap stock with a market cap of about 5.5 billion dollars.

How does Dolby Laboratories make money?

Selling products or services to its customers. Growing sales while controlling costs. Returning extra cash to shareholders in some cases.

What moves DLB stock?

Quarterly results compared with what analysts expected. News about its products, customers and competition. Interest rates and the overall mood of the market.

How can I follow DLB stock every day?

Add DLB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow DLB daily

A free brief on Dolby Laboratories and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • IDCC · InterDigital
  • APPS · Digital Turbine
  • ACTG · Acacia Research

Similar stocks

  • IDCCInterDigital
  • APPSDigital Turbine
  • ACTGAcacia Research

Compare DLB: DLB vs IDCC, DLB vs APPS, DLB vs ACTG

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed